Dear readers! We present to your attention the third issue of the LOGISTICS journal for 2025. Our editorial staff, like all our colleagues, is preparing for the TransRussia 2025 exhibition, the largest event in the industry. In this issue, we have prepared an interview with Natalia Lomunova, Director of TransRussia, with whom we are talking about a flexible approach, new participants and digital services. We continue the series of articles from P.V.
Dear readers! We present to your attention the first issue of the LOGISTICS journal in 2025. First of all, we would like to draw readers' attention to our new partner R1 Development, a development company that creates a new generation environment and specializes in the construction of industrial, logistics, commercial and residential real estate. One of the projects of R1 Development is the Druzhba industrial park network.
Dear readers! We present to your attention the final issue of the LOGISTICS journal in 2024. We have tried to make it rich and interesting. Today, many Russian companies operate under strict sanctions restrictions, which force them to reorient logistics flows. One of the possible solutions to this problem may be the Russia – Mongolia – China economic corridor. Details can be found in the article by Alexandra Kazunina.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
UPS Temperature True® Cryo keeps products frozen at -150°C, and provides monitoring, intervention and financial risk mitigation
BRUSSELS, March 09, 2016 — UPS (NYSE: UPS) announced the launch of UPS Temperature True® Cryo in Europe, providing healthcare customers access to end-to-end product protection and capability to ship specimens in a cryogenic environment. The service includes real-time tracking and intervention, which, when combined with UPS’s risk mitigation solutions and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
This solution uses Cryoport's leading-edge cryogenic containers, which allow UPS customers to use liquid nitrogen stored in dry vapour form to keep products frozen at -150°C for 10 days while in transit or storage. When meeting minimum volume levels, shipments can also be paired with UPS Proactive Response® Secure, a financial protection service that provides coverage for these time- and temperature-sensitive shipments.
"When products requiring cryopreservation are on the move, customers want peace of mind that their shipments are safeguarded, so bringing this solution to the Europe market was a logical next step as we continue to expand our best-in-class logistics services globally for the healthcare and life science industries,” said Jan Denecker, Director of Healthcare Marketing & Strategy, UPS Europe. “UPS Temperature True Cryo combines innovative packaging, 24/7 monitoring and intervention capabilities for the most critical time- and temperature-sensitive specimens across tissue engineering, regenerative medicine, gene therapy, biopharmaceutical research and reproductive health.”
The most recent UPS Pain in the Chain survey, a global study that measures the top pain points in healthcare supply chain management, shows that product security, damage and spoilage continue to be top of mind for healthcare executives. The new UPS Temperature True Cryo service along with UPS Proactive Response Secure, will add tremendous value to researchers, lab technicians and healthcare practitioners shipping often-invaluable specimens and samples requiring cryopreservation.
The UPS Temperature True® portfolio offers broad storage, transportation and packaging services for products ranging from cryogenic to ambient, specifically tailored for companies in the pharmaceutical, biotech and medical device industries. These services are complemented by extensive regulatory expertise and a global network of 51 UPS healthcare-dedicated facilities.
 |
 |
